权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Modeling Effective Health Policies for Colorectal Cancer

为结直肠癌建立有效的健康政策模型

基本信息

批准号：
8727270
负责人：
KAREN M KUNTZ
金额：
$ 92.8万
依托单位：
SLOAN-KETTERING INST CAN RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-09-01 至 2016-02-29
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8727270
关键词：
Address Advisory Committees Age Biological Markers Cancer Control Cancer Etiology Cancer Model Cessation of life Characteristics Collaborations Colorectal Cancer Computed Tomographic Colonography DNA Data Disease Equilibrium Evaluation Fecal occult blood Feces Flexible fiberoptic sigmoidoscopy Funding Future Genomics Goals Guidelines Health Policy Incidence Individual Intervention Malignant Neoplasms Medicare Methods Modality Modeling National Cancer Institute Online Systems Past Trends Pathway interactions Policies Policy Maker Policy Making Preventive Primary Prevention Process Race Randomized Controlled Trials Recommendation Relative (related person)Research Risk Risk Factors Secondary Prevention Services Surveillance Modeling Testing United States Update Washington Work base cancer therapy colorectal cancer screening cost effectiveness experience health disparity improved innovation insight member models and simulation modifiable risk mortality new technology population based screening sex shift work tool treatment strategy trend tumor

项目摘要

DESCRIPTION (provided by applicant): Colorectal cancer (CRC) is still the second most common cause of cancer death in the United States, despite the availability of a range of interventions to reduce the burden of CRC. Microsimulation modeling can inform policy makers in prioritizing among these cancer-control interventions. The CISNET-CRC team includes three collaborative modeling groups, each with a state-of-the-art, population-based microsimulation model for CRC: MISCAN, SimCRC, and CRC-SPIN. These three modeling groups have collaborated for eight years and have delivered a substantial body of policy-oriented work. We propose to continue this collaboration, further developing our models and using them to identify optimal cancer-control policies and practices to reduce the burden of CRC. Our proposed work centers around three specific aims. In Aim 1 we extend our models to reflect the evolving understanding of the CRC disease processes and to incorporate new and updated screening modalities, allowing us to address new policy questions. Here we focus on new data on genomics, biomarkers, pathways, and the upcoming data from randomized controlled trials of flexible sigmoidoscopy screening. In Aim 2 we apply our updated models to inform health policy, including evaluation of interventions across the cancer-control spectrum. New technologies and more individually tailored screening and treatment strategies will be evaluated with a special focus on health disparities. In Aim 3 we disseminate results from our models to inform health policy, via methods that engage policy makers and encourage appropriate use of modeling in policy making and decision support. Here we envision innovation using open-access web-based model applications. We will begin with model extensions required for specific applications, with the balance of the work shifting heavily toward applications over the course of the funding period. Dissemination of our findings will occur throughout the funding period.

描述(申请人提供)：结直肠癌(CRC)仍然是美国癌症死亡的第二大常见原因，尽管有一系列干预措施可以减轻CRC的负担。微模拟建模可以让政策制定者在这些癌症控制干预措施中确定优先顺序。CISNET-CRC团队包括三个协作建模小组，每个小组都有一个最先进的、基于种群的CRC微观仿真模型：MISCAN、SimCRC和CRC-SPIN。这三个建模小组已经合作了八年，并提供了大量以政策为导向的工作。我们建议继续这种合作，进一步开发我们的模型，并使用它们来确定最佳的癌症控制政策和实践，以减轻CRC的负担。我们提议的工作围绕三个具体目标展开。在目标1中，我们扩展了我们的模型，以反映对结直肠癌疾病过程的不断发展的理解，并纳入新的和更新的筛查模式，使我们能够解决新的政策问题。在这里，我们关注关于基因组学、生物标记物、通路的新数据，以及即将到来的柔性乙状结肠镜筛查随机对照试验的数据。在目标2中，我们应用我们最新的模型来为卫生政策提供信息，包括评估整个癌症控制范围内的干预措施。将对新技术和更多针对个人定制的筛查和治疗战略进行评估，特别关注健康差距。在目标3中，我们通过让政策制定者参与并鼓励在政策制定和决策支持中适当使用建模的方法，传播我们的模型的结果，为卫生政策提供信息。在这里，我们设想使用开放访问的基于网络的模型应用程序进行创新。我们将从特定应用程序所需的模型扩展开始，在整个资金期内，工作的平衡将严重转向应用程序。我们的调查结果将在整个筹资期间进行传播。

项目成果

期刊论文数量（17）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Optimising the expansion of the National Bowel Cancer Screening Program.

DOI：
10.5694/mja13.00112
发表时间：
2014-10-20
期刊：
The Medical journal of Australia
影响因子：
0
作者：
Cenin DR;St John DJ;Ledger MJ;Slevin T;Lansdorp-Vogelaar I
通讯作者：
Lansdorp-Vogelaar I

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications.

DOI：
10.1177/0272989x15622642
发表时间：
2016-07
期刊：
Medical decision making : an international journal of the Society for Medical Decision Making
影响因子：
0
作者：
Rutter CM;Knudsen AB;Marsh TL;Doria-Rose VP;Johnson E;Pabiniak C;Kuntz KM;van Ballegooijen M;Zauber AG;Lansdorp-Vogelaar I
通讯作者：
Lansdorp-Vogelaar I

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

DOI：
10.1001/jama.2016.6828
发表时间：
2016-06-21
期刊：
JAMA
影响因子：
0
作者：
Knudsen AB;Zauber AG;Rutter CM;Naber SK;Doria-Rose VP;Pabiniak C;Johanson C;Fischer SE;Lansdorp-Vogelaar I;Kuntz KM
通讯作者：
Kuntz KM

Estimating screening test utilization using electronic health records data.

使用电子健康记录数据估计筛查测试的利用率。

DOI：
10.13063/2327-9214.1109
发表时间：
2014
期刊：
EGEMS (Washington, DC)
影响因子：
0
作者：
Hubbard,Ra;Chubak,J;Rutter,Cm
通讯作者：
Rutter,Cm

Evidence-based sizing of non-inferiority trials using decision models.

使用决策模型基于证据确定非劣效性试验的规模。

DOI：
10.1186/s12874-018-0643-2
发表时间：
2019
期刊：
BMC medical research methodology
影响因子：
4
作者：
Lansdorp-Vogelaar,Iris;Jagsi,Reshma;Jayasekera,Jinani;Stout,NatashaK;Mitchell,SandraA;Feuer,EricJ
通讯作者：
Feuer,EricJ